Cereno Scientific's Phase II clinical trial postponed due to Covid-19
Due to the global spread of the Sars-cov-2 virus Cereno Scientific announces that the company will postpone the planned Phase II clinical trial with the company’s lead compound CS1. The start of the study was previously planned for mid-year 2020. Cereno Scientific is adjusting planned activities to start by the end of the year, but is prepared for further adjustments if needed, due to the uncertainty of the further development of the pandemic.Given the current situation, there are no possibilities to start the Phase II study in elective orthopedic surgery, as planned knee joint surgery is